宁德时代、恒瑞医药及中国宏桥获纳入富时中国50指数，12月22日生效

Core Viewpoint - FTSE Russell announced the quarterly review results for the FTSE China Index Series, effective from December 22, 2025, with changes in constituent stocks for various indices [1] Group 1: FTSE China A50 Index Changes - Two new constituents added: Luoyang Molybdenum (603993) and Sunshine Energy [1] - Two constituents removed: SF Express (002352) and Jiangsu Bank (600919) [1] Group 2: FTSE China 50 Index Changes - Three new constituents added: China Hongqiao, CATL (300750), and Hengrui Medicine (600276) [1] - Three constituents removed: CITIC Securities (601066), Great Wall Motors (601633), and Li Auto [1] Group 3: Future Review Schedule - The next quarterly review for the FTSE China Index will be announced in March [1]